Cited by 58Bone health and osteoporosis researchLGBTQ Health, Identity, and PolicyHIV-related health complications and treatments

Prevalence of Low Bone Mass in Relation to Estrogen Treatment and Body Composition in Male-to-Female Transsexual Persons

T'Sjoen, Guy, Weyers, Steven, Taes, Youri, Lapauw, Bruno, Toye, Kaatje, Goemaere, S., Kaufman, Jean-Marc·2009·Journal of Clinical Densitometry

Abstract

Bone health is a parameter of interest in the daily follow-up of male-to-female (M --> F) transsexual persons both before and after sex reassignment surgery (SRS) due to an intensely changing hormonal milieu. We have studied body composition, areal, geometric, and volumetric bone parameters, using DXA and peripheral quantitative computed tomography at different sites in 50 M --> F transsexual persons, at least 3 yr after the start of the hormonal treatment and 1 yr after SRS. In this cross-sectional study, hormone levels and markers of bone metabolism were assessed using immunoassays. Prevalence of low bone mass as defined by a Z-score < or = -2.0 according to DXA criteria was 26% at lumbar spine and 2% at the total hip. We found no major differences in hormonal parameters between participants with a Z-score < or = or > -2.0. Markers of bone turnover were comparable between subjects with or without low bone mass, indicating a stable bone turnover at the time of investigation. No significant differences in bone size or density were observed between patients on transdermal vs. oral estrogens. Low bone mass is not uncommon in M --> F transsexual persons. Smaller bone size, and a strikingly lower muscle mass compared with men appear to underlie these findings.

Integrity signals

Registry

Crossref · 10.1016/j.jocd.2008.11.002

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a study of 50 non-athlete transwomen who had undergone gender-affirming surgery (GAS) coupled with HRT, a reduction in muscle mass and bone mineral density was reported together with an increase in fat mass following HRT initially and 1 year after GAS.

    “In a study of 50 non-athlete transwomen who had undergone gender-affirming surgery (GAS) coupled with HRT, a reduction in muscle mass and bone mineral density was reported together with an increase in fat mass following HRT initially and 1 year after GAS [48].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
T'Sjoen, G., Weyers, S., Taes, Y., Lapauw, B., Toye, K., Goemaere, S., & Kaufman, J.-M.
Affiliations
Ghent University Hospital (BE)
Corresponding author
T'Sjoen, Guy
Venue
Journal of Clinical Densitometry
Publisher
Elsevier BV
Published
2009-07
Volume
12
Issue
3
Pages
306-313
ISSN
1094-6950 (ISSN-L)
OpenAlex
W2089210484
Cited by
58
References
28
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 8 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 4 · 2013: 3 · 2012: 2
FWCI
2.45
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Densitometry (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Social Sciences › Psychology › Social Psychology › LGBTQ Health, Identity, and Policy
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
Keywords
osteopenia, male-to-female transsexuals, estrogen therapy, body composition, gender-affirming surgery, bone mineral density, bone turnover markers, muscle mass, transdermal estrogen, lumbar spine, hip, bone size
MeSH terms
Administration, Cutaneous, Administration, Oral, Adult, Androgen Antagonists, Body Composition, Cross-Sectional Studies, Estrogens, Feminization, Humans, Male, Middle Aged, Orchiectomy, Osteoporosis, Transsexualism, Prevalence, Case-Control Studies, Bone Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review